Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis is organized by Physicians' Education Resource, LLC (PER).
Release Date: May 15, 2023
Expiration Date: May 15, 2024
Description:
Lid disorders like acquired ptosis and Demodex blepharitis can have a significant impact on visual function and health-related quality of life. Traditional management options for both conditions have efficacy and safety limitations that have largely hindered achievement of optimal outcomes for affected patients. The recent FDA approval of a pharmacologic therapy for acquired ptosis and advanced clinical development of an emerging treatment for Demodex blepharitis will offer optometrists and other eye care professionals additional options for the treatment of these challenging conditions.
This Community Practice Connection™ program provides an in-depth review of some of the key highlights from a satellite symposium held at the Southern Educational Conference of Optometry in March 2023. This unique and engaging multimedia activity is ideal for the community-based optometrist; it focuses on the practical aspects of identifying and treating acquired ptosis and Demodex blepharitis. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Recognize impact on vision and quality of life associated with untreated acquired blepharoptosis
• Develop strategic protocols for prompt and efficient diagnosis and treatment for patients presenting with acquired blepharoptosis
Summarize current gaps in the standard of care for Demodex blepharitis
• Assess clinical evidence evaluating current and emerging therapies for the management of Demodex blepharitis.